287 related articles for article (PubMed ID: 9414082)
21. Persistence of botulinum neurotoxin action in cultured spinal cord cells.
Keller JE; Neale EA; Oyler G; Adler M
FEBS Lett; 1999 Jul; 456(1):137-42. PubMed ID: 10452545
[TBL] [Abstract][Full Text] [Related]
22. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
Carle S; Pirazzini M; Rossetto O; Barth H; Montecucco C
Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29257047
[TBL] [Abstract][Full Text] [Related]
23. A discontinuous SNAP-25 C-terminal coil supports exocytosis.
Chen YA; Scales SJ; Jagath JR; Scheller RH
J Biol Chem; 2001 Jul; 276(30):28503-8. PubMed ID: 11373287
[TBL] [Abstract][Full Text] [Related]
24. Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis.
Koticha DK; McCarthy EE; Baldini G
J Cell Sci; 2002 Aug; 115(Pt 16):3341-51. PubMed ID: 12140265
[TBL] [Abstract][Full Text] [Related]
25. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
Chen S; Barbieri JT
J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
[TBL] [Abstract][Full Text] [Related]
26. A conserved membrane-spanning amino acid motif drives homomeric and supports heteromeric assembly of presynaptic SNARE proteins.
Laage R; Rohde J; Brosig B; Langosch D
J Biol Chem; 2000 Jun; 275(23):17481-7. PubMed ID: 10764817
[TBL] [Abstract][Full Text] [Related]
27. Modulation of L-type Ca(2+) channels by distinct domains within SNAP-25.
Ji J; Yang SN; Huang X; Li X; Sheu L; Diamant N; Berggren PO; Gaisano HY
Diabetes; 2002 May; 51(5):1425-36. PubMed ID: 11978639
[TBL] [Abstract][Full Text] [Related]
28. Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.
He Y; Elias CL; Huang YC; Gao X; Leung YM; Kang Y; Xie H; Chaddock JA; Tsushima RG; Gaisano HY
Pancreas; 2008 Jan; 36(1):10-7. PubMed ID: 18192874
[TBL] [Abstract][Full Text] [Related]
29. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
Chen F; Foran P; Shone CC; Foster KA; Melling J; Dolly JO
Biochemistry; 1997 May; 36(19):5719-28. PubMed ID: 9153412
[TBL] [Abstract][Full Text] [Related]
30. A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.
Fang H; Luo W; Henkel J; Barbieri J; Green N
Proc Natl Acad Sci U S A; 2006 May; 103(18):6958-63. PubMed ID: 16636286
[TBL] [Abstract][Full Text] [Related]
31. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
Keller JE; Neale EA
J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
[TBL] [Abstract][Full Text] [Related]
32. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
[TBL] [Abstract][Full Text] [Related]
33. Specificity of botulinum protease for human VAMP family proteins.
Yamamoto H; Ida T; Tsutsuki H; Mori M; Matsumoto T; Kohda T; Mukamoto M; Goshima N; Kozaki S; Ihara H
Microbiol Immunol; 2012 Apr; 56(4):245-53. PubMed ID: 22289120
[TBL] [Abstract][Full Text] [Related]
34. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
35. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
Hanson MA; Stevens RC
Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol.
Cai S; Sarkar HK; Singh BR
Biochemistry; 1999 May; 38(21):6903-10. PubMed ID: 10346912
[TBL] [Abstract][Full Text] [Related]
37. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
Hallis B; James BA; Shone CC
J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
[TBL] [Abstract][Full Text] [Related]
38. Tetanus and botulism neurotoxins: a novel group of zinc-endopeptidases.
Tonello F; Morante S; Rossetto O; Schiavo G; Montecucco C
Adv Exp Med Biol; 1996; 389():251-60. PubMed ID: 8861019
[TBL] [Abstract][Full Text] [Related]
39. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.
Bajohrs M; Rickman C; Binz T; Davletov B
EMBO Rep; 2004 Nov; 5(11):1090-5. PubMed ID: 15486565
[TBL] [Abstract][Full Text] [Related]
40. Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A.
Rigoni M; Caccin P; Johnson EA; Montecucco C; Rossetto O
Biochem Biophys Res Commun; 2001 Nov; 288(5):1231-7. PubMed ID: 11700044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
